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Abstract
Aging is associated with profound changes in the structure and function of the heart. A fundamental
understanding of these processes, using relevant animal models, is required for effective prevention
and treatment of cardiovascular disease in the elderly. Here, we studied cardiac performance in 4-
to 5-mo-old (young) and 24- to 26-mo-old (old) Fischer 344 male rats using the Millar pressure-
volume (P-V) conductance catheter system. We evaluated systolic and diastolic function in vivo at
different preloads, including preload recruitable stroke work (PRSW), maximal slope of the systolic
pressure increment (+dP/dt), and its relation to end-diastolic volume (+dP/dt-EDV) as well as the
time constant of left ventricular pressure decay, as an index of relaxation. The slope of the end-
diastolic P-V relation (EDPVR), an index of left ventricular stiffness, was also calculated. Aging
was associated with decrease in left ventricular systolic pressure, +dP/dt, maximal slope of the
diastolic pressure decrement, +dP/dt-EDV, PRSW, ejection fraction, stroke volume, cardiac and
stroke work indexes, and efficiency. In contrast, total peripheral resistance, left ventricular end-
diastolic volume, left ventricular end-diastolic pressure, and EDPVR were greater in aging than in
young animals. Taken together, these data suggest that advanced aging is characterized by decreased
systolic performance accompanied by delayed relaxation and increased diastolic stiffness of the heart
in male Fischer 344 rats. P-V analysis is a sensitive method to determine cardiac function in rats.
Keywords
systolic dysfunction; diastolic dysfunction
In the absence of obvious disease, the major anatomic changes seen in the aging human heart
are primarily an increase in ventricular wall thickness, myocardial fibrosis, and valvular
fibrocalcification, which lead to reduced ventricular compliance (26). In addition, loss of
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arterial elasticity produces a widening of arterial pulse pressure and reduction of the diastolic
pressure that largely determines coronary artery perfusion. Aging also imposes a ceiling on
maximal cardiac output (CO) that reflects both reduced maximal heart rate (HR) and the age-
related prolongation of time required for both myocardial contraction and relaxation (25,26).
In a variety of mammals, including dogs and rodents, aging is also associated with hypertrophy,
dilatation, and fibrosis of the left ventricle (LV) (1-3,5-11,21,25,37-39). A fundamental
understanding of these processes, using relevant animal models, is required for more effective
prevention and treatment of cardiovascular disease in the elderly. The Fischer 344 (F344) rat,
developed by the National Institute on Aging, is an inbred rat model that is commonly used
for aging studies. It has a longer lifespan, smaller body size, and lower spontaneous tumor rate
than noninbred rats and resemble many features of aging humans. The F344 rat has served as
a model to assess the mechanisms of age-related changes in the heart and their implications
for the response of the heart to physiological and pathological challenges (1-3,5-11,21,
37-39).
The major limitation of the previously used invasive and noninvasive approaches to study the
cardiac function in small animal models is that the hemodynamic parameters measured were
largely dependent on loading conditions. Pressure-volume (P-V) analysis is a useful approach
for examining intact chamber function independently of loading conditions. This analysis has
been widely used in large animal studies and in humans (22-24,27,31,36). Recent advances in
the development and validation of miniature P-V catheters has made it possible to use this
approach for studies in small animals (16,18,19,29,32,41). Although P-V loop analysis is
widely used in mice, the combined P-V conductance catheter for rats has been introduced only
recently, and very limited normative data are available.
Here, we aimed to characterize the baseline cardiac performance and systolic and diastolic
function at different preloads in aging F344 male rats using the Millar P-V conductance catheter
system.
METHODS
This investigation conformed to the National Institutes of Health Guide for the Care and Use
of Laboratory Animals (NIH Pub. No. 85-23, Revised 1996) and was performed with the
approval of the local Institutional Animal Care and Use Committee.
Animals
Male F344 rats were obtained from the National Institute on Aging at 3 (n = 12) and 24 mo of
age (n = 20) and studied 1–2 mo later. Rats were housed two to three per cage, fed a standard
laboratory diet and water ad libitum, and maintained on a 12:12-h light-dark cycle. During the
observation period, ~50% of the aging and none of young control rats died, and autopsy
revealed in most of the cases large dilated hearts and marked fluid accumulation in the chest
cavity.
Hemodynamic measurements
Rats were anesthetized with thiopental sodium (60–80 mg/kg ip): aging animals with heart
failure required ~15–20% less anesthetic than young rats. The animals were tracheotomized
to facilitate breathing and placed on controlled heating pads. The core body temperature
measured via a rectal probe was maintained at 37°C. A microtip P-V catheter (SPR-838, Millar
Instruments; Houston, TX) was inserted into the right carotid artery and advanced into the LV
under pressure control as described previously (32-34). Polyethylene (PE) catheters (PE-50)
were inserted into the right femoral artery for measurement of mean arterial pressure (MAP)
and the right femoral vein for fluid administration. After stabilization for 20 min, the signals
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were continuously recorded at sampling rate of 1,000/s using an ARIA P-V conductance system
(Millar Instruments) coupled to a PowerLab/4SP A/D converter (AD Instruments; Mountain
View, CA) and a personal computer.
HR, maximal LV systolic pressure (LVSP), LV end-diastolic pressure (LVEDP), MAP,
maximal slope of systolic pressure increment (+dP/dt) and diastolic pressure decrement (−dP/
dt), time constant of LV pressure decay (τ), ejection fraction (EF), stroke volume (SV), end-
diastolic volume (EDV), CO, and stroke work (SW) were computed using a cardiac P-V
analysis program (PVAN3.2, Millar Instruments) as described previously (13,32). SV and CO
were calculated and corrected according to in vitro and in vivo volume calibrations using
PVAN3.2 (32). CO and SW were normalized to body weight [cardiac index (CI) and SW index
(SWI)]. The total peripheral resistance index (TPRI) was calculated by the following equation:
TPRI = MAP/CI.
LV P-V relations were assessed by transiently compressing the inferior vena cava. Indexes of
contractility and LV stiffness {preload recruitable stroke work (PRSW), +dP/dt-end-diastolic
volume relation (+dP/dt-EDV), slope of end-systolic and end-diastolic P-V relations [ESPVR
(Emax) and EDPVR]} as well as the efficiency of LV work [SW/P-V area (PVA)] were
calculated using PVAN3.2.
The volume calibration of the conductance system was performed as described previously
(32,31). Briefly, nine cylindrical holes in a block 1 cm deep and with known diameter ranging
from 2 to 11 mm were filled with fresh heparinized whole rat blood. In this calibration, the
linear volume-conductance regression of the absolute volume in each cylinder versus the raw
signal acquired by the conductance catheter was used as the volume calibration formula (29,
32,41). At the end of each experiment, 50 μl of 15% saline were injected intravenously, and
from the shift of P-V relations parallel conductance volume (Vp) was calculated by PVAN 3.2
and used for correction for the cardiac mass volume as described previously (32,41).
Cardiac remodeling
After the hemodynamic measurements, the animals were killed by exsanguination (transsection
of the inferior vena cava). The heart was removed, and the LV and right ventricle were dissected
and weighed (the septum was included in the LV weight). The weight of each ventricle was
then normalized to body weight. The lungs were also removed and weighed. Wet lung weights
were normalized to body weight, and the ratio was used as an index of pulmonary congestion
(28,33).
Statistical analysis
An unpaired two-sided Student’s t-test was used to compare tissue weights and hemodynamic
parameters of aging and young rats. Values of P < 0.05 were considered statistically significant.
RESULTS
Cardiac remodeling
Aging was associated with a significant increase in the weight of the LV but not the right
ventricle: LV weights in young (4–5 mo old, n = 8) and aging (24–26 mo old, n = 10) rats
normalized to body weight were 1.7 ± 0.05 and 2.4 ± 0.05 mg/g, respectively (P < 0.05),
whereas the normalized right ventricular weights were 0.4 ± 0.01 and 0.4 ± 0.03 mg/g,
respectively. In addition, wet lung weight normalized to body weight was also significantly
increased in aging animals compared with the young controls (5.9 ± 0.3 vs. 4.5 ± 0.26 mg/g,
respectively, P < 0.05), indicating marked pulmonary congestion secondary to cardiac
decompensation.
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Cardiac function
Figure 1 shows typical P-V loops (top) and the pressure signal and dP/dt (bottom) obtained
from young and aging animals. The shift of the P-V loops to the right and the decreased
amplitude and +dP/dt in aging rats indicates a decrease in cardiac contractility. As shown in
Table 1, aging was associated with decreased MAP, LVSP, +dP/dt, −dP/dt, EF, SV, CI, and
SWI. In contrast, LVEDP, τ, and EDV were increased in aging animals, indicating diastolic
dysfunction. TPRI was also increased in aging rats. There was a slight (11%) but not significant
decrease in the HR of aging animals (Table 1).
Figure 2 displays typical P-V loops obtained after inferior vena cava occlusions in aging
(bottom) and young (top) rats. Overall results of EDPVR and ESPVR (Emax) are depicted in
Table 1. As shown in Fig. 2 and Table 1, ESPVR was steeper in young animals, suggesting
decreased systolic performance in aging rats. In contrast, EDPVR was increased in aging rats,
indicating increased end-diastolic stiffness. In addition to the above parameters, P-V loops
recorded at different preloads can be used to derive other useful systolic function indexes that
may be less influenced by loading conditions and cardiac mass, such as PRSW and +dP/dt-
EDV (24,27,36) (Fig. 3).
PRSW represents the slope of the relation between SW and EDV. It has been described as
independent of chamber size and mass, and it is sensitive to chamber contractile function
(22,23). Figure 3, top, shows PRSW in a young and an aging animal. The slope is steeper in
the young rat than in the aging rat, indicating decreased systolic performance in the aging
animal. The overall PRSW was significantly higher in young rats (Fig. 3, top, inset).
We also determined the relation between +dP/dt and EDV. +dP/dt is a classic parameter that
is sensitive to changes in contractility but dependent on changes in preload. Analysis of +dP/
dt-EDV allowed us to compare +dP/dt of aging and young rats at a given EDV. Figure 3,
bottom, shows that the slope of this relation was steeper in young rats, indicating a decreased
contractility in aging.
Efficiency of LV work was also decreased in aging rats compared with young rats (Table 1).
DISCUSSION
To our knowledge, this is the first study to characterize the systolic and diastolic function in
an advanced aging-associated heart failure model using a P-V conductance catheter system.
Here, we show that advanced aging is characterized by decreased systolic performance
accompanied by delayed relaxation and increased diastolic stiffness of the heart.
We found that aging was associated with decreased +dP/dt and EF (Table 1). Although +dP/
dt has been widely used as a cardiac contractile parameter, it is well recognized that it is load
dependent, especially on changes in preload (22-24,27). EF is also known to be influenced by
both preload and afterload and, therefore, cannot reliably be used to assess the contractile
function in the models where both preload and afterload are altered.
Historically, ESPVR (Emax) was proposed as a fairly load-insensitive index of contractility.
ESPVR was decreased in aging rats. However, because this relation can be altered not only by
changes in inotropic state but also by changes in chamber geometry and other diastolic factors,
we also calculated other parameters (22,23,31).
PRSW, the linear relation between SW and EDV, may be sensitive to changes in systolic
function. It has advantage of being stable in the hearts of different sizes. Although it integrates
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data from the entire cardiac cycle, it is influenced most of all by systole (22,23). PRSW was
also decreased in aging rats compared with young controls.
Previous investigations (24,27) have demonstrated that +dP/dt-EDV, another P-V-derived
index, represents a sensitive but less load-dependent parameter of chamber contractility. In
previous studies, the slope of this relationship increased and shifted leftward with increased
contractility, and it decreased and shifted rightward with depressed contractility. We found
that this index was also depressed in aging animals compared with young controls.
Our baseline hemodynamic data obtained with the P-V system are in a good agreement with
the results of Capasso et al. (9). In that study, F344 rats were anesthetized with chloral hydrate
(300 mg/kg ip) followed by measurements of ventricular pressure-derived parameters and
ascending aortic flow. From 20 mo of age, there was an elevation in LVEDP, a significant
decrease in +dP/dt and −dP/dt, a reduction of SV and CO, and an increase in total peripheral
resistance. At 29 mo of age, EF, +dP/dt, −dP/dt, SV, CO, and HR were reduced by 59, 38, 48,
27, 40, and 17%, respectively, whereas LVEDP and total peripheral resistance increased by
275 and 59%, respectively (9). Similarly, in our study in barbiturate-anesthetized F344 male
rats using P-V analysis, at 26 mo of age, EF, +dP/dt, −dP/dt, SV, CI, and HR were reduced by
43, 36, 41, 29, 44, and 11%, respectively, whereas LVEDP and total peripheral resistance
increased by 139 and 41%, respectively (Table 1). In addition to the baseline parameters of
contractility, we showed that all load-independent indexes of LV contractility (see above and
also Table 1 and Figs. 2 and 3) demonstrate decreased contractile pump function in aging rats.
The indexes of LV failure were accompanied by alterations in ventricular size and shape
consisting of increases in the transverse and longitudinal chamber diameters and an abnormal
expansion in diastolic and systolic ventricular chamber volumes. Consistent with the expansion
of the diastolic chamber volume in the previous report (9), we also observe an increase in EDV
in aging F344 rats using the P-V system (Table 1). A similar age-associated decline in cardiac
function was also reported in mice using the P-V technique (41).
In a more recent study, Boluyt et al. (5) confirmed both systolic and diastolic dysfunction in
isoflurane-anesthetized 30-mo-old female F344 rats using echocardiographic assessment.
However, in the latter study, the reduction of systolic performance was less pronounced (EF
and fractional shortening were decreased by 9 and 25%, respectively) than it was demonstated
by Capasso et al. (9) and by the present investigation (see above). The reason for the less
depressed systolic function found by Boluyt et al. (5) can be the protection against development
of the cardiac dysfunction and heart failure in female F344 rats compared with male rats used
in the previous (9) and our present studies.
One can also argue that aged rats are more sensitive to the cardiovascular depressant effects
of barbiturate anesthesia than younger animals, and this could have a significant impact on the
magnitude of changes noted in the aged versus younger animals. Although there is no perfect
pharmacological agent available for anesthesia in the elderly, dozens of clinical studies have
arrived to the same conclusion that no significant difference in outcome can be attributed solely
to use of any specific anesthetic agent (4). Barbiturates have been a standard element of
anesthesia practice both in the young and elderly patients for more that 50 years. Individual
variability in response to thiopental is well known. In elderly patients, an age-related decrease
in the initial distribution volume or differences in clearance to the rapidly equilibrating
compartments were found (20). Compared with younger patients, geriatric patients require a
20–30% lesser induction dose (12). On the basis of the latter study, we also used a reduced
dose of the drug in our aging rats (see METHODS). The predominant cardiovascular effect of
thiopental is venodilation, followed by pooling of blood in the periphery (14). Myocardial
contractility may be depressed, but not to the extent seen after volatile anesthetics (17).
Importantly, barbiturates do not sensitize the heart to cathecholamines. Systemic vascular
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resistance usually remains unchanged, and no arrhythmia occurs. We have successfully used
barbiturates for anesthesia in various rat models of shock, myocardial infarction, and heart
failure and reported comparable, if not better, hemodynamic parameters than using inhalation
agents (15,33,34). In a previous study (35) using 22-mo-old aging Wistar rats, we reported
impaired endothelial nitric oxide-mediated dilation of isolated aortic rings without any
depression of systolic cardiac function using the same anesthesia protocol. Thus it is unlikely
that the increased sensitivity of aging animals to thiopental could have a significant contribution
to the hemodynamic changes observed in the present study.
Impaired ventricular relaxation and increased end-diastolic stiffness were also observed in
aging animals, as reflected by the decreased −dP/dt, prolonged τ, and increased LVEDP and
EDPVR. Relaxation, an active process, depends mostly on calcium uptake by the sarcoplasmic
reticulum during diastole, and under normal conditions usually takes place during the first third
of diastole. End-diastolic stiffness is predominantly affected by alterations in myocardial
structural components; however, it may also be influenced by various other factors. We
observed both delayed relaxation and increased stiffness in aging rats. Consistent with diastolic
dysfunction, LVEDP was also increased in aging animals.
Potential limitations of the study
P-V loop analysis, which is widely used in mice, has become a prerequisite for the assessment
of LV function because it is the only technique that allows measuring the LV performance
independently from loading conditions. The combined pressure-conductance probe for rats has
been introduced only recently, and limited normative data are available. The proper
measurement of absolute volumes is the most vulnerable part of the P-V technique, especially
in a situation that requires the comparison of groups with markedly different ventricular sizes.
In these conditions, problems could arise from the potential limitation in the construction of
the probe, which has only two pairs of conductance electrodes at the fixed distance from each
other. Nevertheless, as our results demonstrate, the baseline P-V data are very similar to the
earlier data obtained by using flow measurements in the same aging-associated heart failure
model (9). Importantly, our baseline SV data in control young adult rats are very similar to the
data recently obtained by MRI (124.3 ± 8.8 vs. 126.8 ± 8 μl) (30), also suggesting that in most
earlier studies the rat SV and CO were markedly overestimated.
Because aging is also associated with vascular dysfunction and remodeling, it is conceivable
that the impairment of vascular function and the aging-associated decrease in cardiac
contractility and heart failure are interrelated: an impairment of endothelial function may lead
to global or regional myocardial ischemia, which may secondarily impair cardiac performance.
Therefore, myocardial aging in this model should rather be interpreted as a time-dependent
biological process that interacts with ischemic heart disease and other pathological conditions,
which together define the phenotype.
In conclusion, our data demonstrate decreased systolic performance accompanied by delayed
relaxation and increased diastolic stiffness of the heart in the advanced model of aging-
associated heart failure using the Millar P-V conductance catheter system. The P-V
methodology could be a very useful approach for the assessment of LV function in various
pathophysiological conditions associated with cardiac dysfunction and/or heart failure in rats,
and, furthermore, it could be successfully applied to evaluate potential pharmacotherapies
against these conditions.
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Fig. 1.
Representative pressure-volume (P-V) loops (top) and pressure signals and dP/dt (bottom)
obtained with the Millar P-V conductance catheter system from aging and young rats. The
rightward shift of the P-V loop and decrease of the amplitude of the pressure signal and +dP/
dt indicates decreased contractility in aging rats compared with young controls.
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Fig. 2.
Representative P-V loops obtained with a P-V conductance catheter system at different
preloads, showing differences in the end-systolic P-V relation (ESPVR) and end-diastolic P-
V relation (EDPVR) between young (top) and aging rats (bottom). The less steep ESPVR and
increased EDPVR in aging animals indicate decreased contractile function and increased
diastolic stiffness.
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Fig. 3.
Relation between stroke work (SW) and end-diastolic volume (EDV; top) and between +dP/
dt and EDV (bottom) for a young (●) and an aging rats (▲). PRSW, preload recruitable SW.
Insets: overall slope values as means ± SE of 8–10 experiments in each group. *P < 0.05 vs.
young rats. Note that for both relationships, slope values are higher in young than in aging rats,
suggesting that systolic performance is decreased in aging rats.
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Table 1
Hemodynamic parameters in young and aging rats measured by the Millar pressure-volume conductance catheter
system
Young Aging
HR, beats/min 403.1±11.6 359.2±20.2
MAP, mmHg 109.2±3.1 83.6±2.0*
LVSP, mmHg 133.1±6.1 98.4±2.3*
LVEDP, mmHg 3.8±0.9 9.1±0.6*
CI, ml·min−1·100 g−1 13.7±1.4 7.6±0.7*
EF, % 72.7±7.0 41.6±5.4*
SWI, mmHg·ml·100 g−1 4,612±590 1,850±198*
+dP/dt, mmHg/s 9,327±556 5,975±204*
−dP/dt, mmHg/s 7,721±546 4,580±298*
τ (Weiss), ms 7.8±0.4 11.2±0.6*
τ (Glantz), ms 11.5±0.4 15.9±0.2*
TPRI, mmHg·ml−1·min−1·100 g−1 8.2±0.5 11.6±1.1*
SV, μl 124.3±8.8 87.9±7.6*
EDV, μl 199.2±14.4 263.2±17.5*
Emax, mmHg/μl 2.6±0.2 1.2±0.2*
EDPVR slope, mmHg/μl 0.021±0.003 0.04±0.004*
Efficiency, % 66.2±1.9 43.4±2.2*
Values are means ± SE; n = 8–10 experiments. HR, heart rate; MAP, mean arterial pressure; LVSP, left ventricular (LV) systolic pressure; LVEDP, LV
end-diastolic pressure; CI, cardiac index; EF, ejection fraction; SWI, stroke work index, +dP/dt and −dP/dt, maximal slope of the systolic pressure increment
and diastolic pressure decrement, respectively; τ, time constant of LV pressure decay; SV, stroke volume; EDV, end-diastolic volume; Emax, maximum
elastance; EDPVR, end-diastolic pressure-volume relation.
*
P < 0.05 vs. young.
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